The heart of NYU Wagner's programs is our faculty. An amalgam of full-time, clinical/research/visiting, and adjunct professors, they are outstanding teachers, expert researchers and committed practitioners.
A report released Feb. 17, 2009, by New York City Mayor Michael Bloomberg found that the city's average annual temperatures could increase by 4 to 7.5 degrees, yearly rainfall will increase by 5 to 10 inches, and seas could rise by up to 23 inches, or even 55 inches if the rate of ice melt in Greenland and Antarctica persists in speeding up.
NYU Wagner Professor Rae Zimmerman is a member of the expert panel convened by the city government and financed by a $350,000 grant from the Rockefeller Foundation. Professor Zimmerman is Director of the Institute for Civil Infrastructure Systems (ICIS), housed at the Robert F. Wagner Graduate School of Public Service at New York University.
The panel also predicted more frequent and intense "extreme events," like heat waves, short periods of intense rain, droughts, and coastal flooding.
The report is entitled "Climate Risk Information" and can be seen by clicking on the link below.
The Financial Access Initiative (FAI), a research consortium based at New York University's Robert F. Wagner Graduate School of Public Service, has identified that 2.5 billion adults worldwide do not have a savings or credit account with either a traditional (regulated bank) or alternative financial institution (such as a microfinance institution). Nearly 90% of the financially un-served live in Asia, Africa, the Middle East and Latin America. FAI published the findings in a November, 2009, paper, "Half the World is Unbanked" (click below to access it).
"Until now, the margin of error when considering the world's unbanked was about plus or minus a billion-unacceptable in any other field," said Jonathan Morduch, professor of economics and policy at NYU Wagner, managing director of the Financial Access Initiative, and author of Portfolios of the Poor, a new book examining the surprisingly sophisticated financial lives of the world's poor. "These findings are a real step ahead, and they show how better data can help policymakers truly target and serve poor populations with appropriate financial services."
The analysis also revealed new insights; for example, that India, a country with low per capita income and a large rural population, demonstrates much greater use of financial services than many relatively richer and more urban countries. The global data indicate that countries can improve levels of financial inclusion by creating effective policy and regulatory environments and enabling the actions of individual financial service providers. More than 800 million of those using financial services live on less than $5 per day, so it is possible to provide these services to very low-income communities-but there are still nearly 2 billion to reach.
The Financial Access Initiative (FAI) is a consortium of leading development economists focused on substantially expanding access to quality financial services for low-income individuals, offering the next generation of thinking about microfinance. FAI is housed at the Wagner Graduate School of Public Service at New York University and led by managing director Jonathan Morduch and directors Dean Karlan (Yale University) and Sendhil Mullainathan (Harvard University). FAI focuses on basic research and measurement tools that reveal the most effective means of implementing microfinance initiatives. FAI studies the value of microfinance by identifying the demand for financial services; the impact of financial access on incomes, businesses, and broader aspects of well-being; and mechanisms that can increase impact and scale of microfinance.
The AIDS pandemic is only the most visible and urgent of the many health challenges facing citizens in developing countries; others include malaria, drug-resistant tuberculosis, childhood diseases and inadequate maternal and prenatal healthcare. This burden of disease causes staggeringly high mortality rates among the poor in the Third World, especially in sub-Saharan Africa.
Public health experts increasingly argue that there is an intrinsic linkage between the health condition of a nation’s people and the potential economic growth needed for a nation to develop. They make the case that good health is a necessary predicate to, not just a result of, economic development.
On February 28th, Harold Varmus, MD, president and CEO of Memorial Sloan-Kettering Cancer Center, co-recipient of the 1989 Nobel Prize in medicine, and former Director of the National Institutes of Health, delivered the 2nd Annual Arnold Schwartz Memorial Health Lecture at the Wagner School. Entitled “Globalizing Biomedical Sciences,” Dr. Varmus’ address outlined the significant themes of his vision for a more active approach by developed countries for tackling the public health challenges faced by the developing world.
Despite great strides in medical and scientific research during the 20th Century –such as the discovery of cures for malaria and tuberculosis – there remains, said Dr. Varmus, a great disparity between health outcomes in rich and poor countries. He lays the blame for this in part on a failure to focus research dollars or to apply discovered solutions towards actually addressing public health problems in the developing World.
“We have had a very successful century scientifically, but one that is subject to criticism with respect to health outcomes, the equity with which we apply solutions, our ability to find solutions, and our willingness to invest in some of the diseases that are most rampant in poor parts of the world. What can those of us who are scientists interested in health do to make the next century a better one?” asked Dr. Varmus. In response, he proposes three solutions:
The Arnold Schwartz Memorial Health Lecture is named for the late Arnold Schwartz, a founder of Paragon Oil Company and well-known health and education philanthropist. His widow Marie Schwartz, a NYU Life Trustee, made a gift of $100,000 to the Wagner School to endow this lecture series, now in its second year. Last year’s inaugural speaker was Yale Medical School Dean David A. Kessler, MD, the former commissioner of the US Food and Drug Administration.